chrisvoncsefalvay/vaers-outcomes huggingface dataset:
dizzy; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy) and HEADACHE (Bad headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced DIZZINESS (dizzy) and HEADACHE (Bad headache). At the time of the report, DIZZINESS (dizzy) and HEADACHE (Bad headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment details were not provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Feb-2021 and was forwarded to Moderna on 06-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy) and HEADACHE (Bad headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 05-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced DIZZINESS (dizzy) and HEADACHE (Bad headache). At the time of the report, DIZZINESS (dizzy) and HEADACHE (Bad headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment details were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
I have daily fever of 99-100,6 especially in the morning, tired. I would like to know if will be safe to take the second dose.
Beginning 1/4, woke with intense itching on entire body and hives. Continued and increased with red lines across body. Saw dermatologist 1/10 who cited cause as likely from booster. Began Allegra 180 mg twice daily, which helps control the itch. Hives still appear as well as dermatographia. Seeing allergist this week.
The patient presented with redness and swelling and visited her PCP and they found she had an infection and prescribed an Antibiotic. She was advised to stay at home and rest for one day.
Had a DTaP at his last visit 1/8/18. Had fever and irritability starting 2 hours after the vaccine. Fever got up to 102F. The next day his behavior seemed abnormal. He was fussy and unhappy. He was hitting at mom. Nursed a lot and refused to eat or drink. The next day he was really lethargic and did not have interest in things like reading books, which he normally loves. He was sleeping a lot. He seemed to be gagging some randomly, but did not vomit. He still seemed really irritable. He tried for over 24 hours solid and was inconsolable. 3 days after the vaccine he stopped nursing and would not take anything by mouth. His urine output decreased. He was inconsolable. They took him to urgent care, who then transferred him to ER, where he was diagnosed with otitis media and tachycardia.  Parents declined the amoxicillin prescribed. They gave him topical garlic mullein drops in the ears, DTaP homeopathics, and Thuia. He started nursing again the next day, and seemed to start feeling better. For two weeks after that he seemed really clingy and "like his nervous system was on edge."  Parents took him in for chiropractic treatments. It took two weeks for his behavior to return to baseline. They feel he is now recovered. His history is very concerning for encephalopathy from the pertussis component of the vaccine, which is reported as a very rare complication on the CDC website. Unfortunately I did not have the opportunity to examine him during this reaction. At his well child check on 3/12/18, his growth and development were normal. He did have a behavior where he was jutting out his chin repetitively, but not other abnormal behaviors were noted.
Seconds after I received the vaccine, I experienced itched and a rash all over my body for one day, my left hand was swollen for almost 15 days,  the hand was red, hot, and receiveful, I felt tired for a couple of days.  I also notice my left leg knee got swollen and still swollen.
Pt had TDAP vaccines at Dr's office and developed fever, redness and swelling to left arm at injection site for 2 days.  Pt then developed abdominal pain for 1 day. Pt came to the urgent care in to seek medical care.
After waiting in the monitoring bay for 15 minutes, patient approached the checkout desk. Upon screening, patient endorsing mild nausea. Denies having nausea prior to vaccine. Denies any other symptoms, and asking if it's alright to workout tonight. Encouraged patient to rest, hydrate, and to contact PCP or EMS if symptoms worsen.
Delayed reaction; Feels dizzy; Weakness specially in the legs; Chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Delayed reaction), DIZZINESS (Feels dizzy), MUSCULAR WEAKNESS (Weakness specially in the legs) and CHILLS (Chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced VACCINATION COMPLICATION (Delayed reaction), DIZZINESS (Feels dizzy), MUSCULAR WEAKNESS (Weakness specially in the legs) and CHILLS (Chills). At the time of the report, VACCINATION COMPLICATION (Delayed reaction), DIZZINESS (Feels dizzy), MUSCULAR WEAKNESS (Weakness specially in the legs) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Fever of 102 or higher (not checked, but assumed by patient). Chills, aches, site of injection redness, swelling, blotchiness. Itching at injection site for 3 days post reaction.
Fever; Pain at injection site; Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), VACCINATION SITE PAIN (Pain at injection site) and PAIN IN EXTREMITY (Pain in arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced PYREXIA (Fever). In April 2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site) and PAIN IN EXTREMITY (Pain in arm). In April 2021, VACCINATION SITE PAIN (Pain at injection site) and PAIN IN EXTREMITY (Pain in arm) had resolved. On 23-Apr-2021, PYREXIA (Fever) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered PYREXIA (Fever) to be possibly related. No further causality assessments were provided for VACCINATION SITE PAIN (Pain at injection site) and PAIN IN EXTREMITY (Pain in arm).    Concomitant product use was unknown by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-246782.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 at 17:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 58 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Psoriasis" (unspecified if ongoing); "Eczema" (unspecified if ongoing); "Known allergies: Yes" (unspecified if ongoing), notes: Known allergies: Yes. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Nov2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient received COVID-19 Treatment, brand was Paxlovid, treatment start date was 22Nov2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
about 7 hours after receiving the vaccine, I developed strong muscle and joint pain, fatigue, and a fever.  Overnight the fever got worse and I developed a headache.  I also felt tired.  A hot shower and some Advil about 24 hours after the vaccine helped.  Within 24 hours of symptom onset, they were better/gone.
I'm very sick; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I'm very sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I'm very sick). At the time of the report, ILLNESS (I'm very sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
little bit of a sore arm; This is a spontaneous report from a contactable consumer. A 78-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL9266) via an unspecified route of administration, administered in left arm on 16Feb2021 at a single dose for COVID-19 immunization. Medical history included ongoing osteoporosis and Degenerative vertebrae and covid. Concomitant medication included calcium lactate and ubidecarenone (COQ-10). The patient experienced little bit of a sore arm on an unspecified date. Patient had Covid and she had no effect and showed no effect at all. The patient underwent lab tests and procedures which included covid-19 positive. The outcome of the event was unknown.
woke up morning after vaccination and was experiencing dizziness after rising.  Still experiencing  dizzines today March 9, 2021
About 45 minutes after receiving the vaccine starting at about 1:15 pm into the evening, I noticed some slight numbness in my lower jaw on both sides. As far as fatigue, I felt pretty tired yesterday evening. I obtained a decent night sleep (around 7-7.5 hours). I initially woke up feeling pretty good, but then after being up for about an hour I felt pretty tired again (so much so that I questioned whether I could make it through the work day). I'm at work now and still feel tired; when I stand up I almost feel a little light-headed.  I'm noticing a little returning of the numbness in my jaw area and short-lived, slight radiating down my right neck.  I listed muscle pain because my right shoulder is also sore in addition to the injection site.   I'm not sure if it's important to share here that I am lactating. I did get clearance from my PCP and provided that note when I submitted my consent.
Dull, centralized back pain extending into the chest; breathlessness. Dissipated over time, no interventions. Episode lasting < 10 minutes. Isolated incident, presenting on second dose only.
Mother brought baby to immunization clinic for 6 month vaccinations. Rotavirus(RotaTeq)po was given, within seconds child was gasping and appeared to be choking. I looked in mouth, saw nothing. I told receptionist to call EMS and took child down hall while delivering back thrusts. EMT met me in the hall and took baby, at which time child started to cry. EMT checked heart and lungs, and determined that child was stable. Advised Mother to take child to medical clinic for evaluation. Other vaccines were deferred to a later date. Physician saw child and discharged him to go home with out any treatment.  Fix city in patient's address and correct date in box 10.
Began running low grade fever next morning, by evening the temp was 100 . I had no energy an began to fall asleep in the early evening.. Woke up in a sweat. Felt exhausted all the next day but temperature left. Should be almost normal by tomorrow. I hope.
Reports malaise, achy, fatigue. Had fever with sweats. Lt arm extreme pain.
Vaccine that administered beyond use date after the thaw process/expired vaccine administered; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 17-Jan-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 17-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine that administered beyond use date after the thaw process/expired vaccine administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 59 year 8 months.  No concomitant medications were reported  No treatment medications were reported  It was unknown if patient had acute illness at the time of vaccination and up to one month before. It was unknown if patient had been diagnosed with or tested positive for COVID-19.  Patient reported no adverse reactions after the administration of vaccine.
Pt c/o cough, vomiting, low BP, weakness, dizziness, SOB x 1 wk. + covid in ED; CXR clear; Labs: D-dimer 0.64 CRP <.20; Lactic Acid 2.98, Ferritin 411.44  TX: started on Maxipime, Decadron, Remdesivir, Rocephin, Vit D3, Vit B12, Lovenox, Singulair, zinc; O2 @ 3 LPM NC with admit; down to room air at d/c
chills, headache, nausea, joint pain, breathing problems, lethargic,
Flushed, nauseous, dizzy, back pain. BP checked, EMS called, patient recovered.
06Dec96 pt recv 1 dose vax. 03Jan98 pt to MD w/2 nights decreased sleep, irritability, 1day severe arm pain,lethargy,poor appetite & rash.5-10 scaly lesions on right arm.Pt tx w/codeine,acyclovir & acetaminophen. No previous exp to varicell
Observation 8/24/22-8/25/22 Fall, constipation, diarrhea, abdominal pain, dizziness, colitis, leukocytosis,
Hospitalization due to SARS-CoV-2 in a previously fully vaccinated individual
Myalgias, arthalgias, and headache starting at 12 hours after vaccine. These lasted 24 hours. Fever, chills, and nausea starting at 22 hours after vaccine and lasted for 14 hours. L axilla lymphadenopathy starting 38 hours after vaccine.   Treatment was tylenol and ibuprofen prn.
HIVES ON BACK; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070, and batch number: 1802070 expiry: UNKNOWN) .5 ml, administered on 09-MAR-2021 to Right Deltoid for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced hives on back. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hives on back. This report was non-serious.
Patient with 2 Moderna COVID vaccinations, last dose 03/10/22, who admitted with concurrent influenza and COVID infection.  Provider discharge note below:  "Indication for Admission: COVID and influenza   Hospital Course: Oxygen using elderly man with multiple medical problems presents with respiratory symptoms and ER evaluation demonstrates co-infection with COVID-19 and influenza.  CXR notes chronic lung disease.  Patient admitted and did remarkably well, improved on Decadron, Tamiflu and increased oxygen support.  Arrangements made to continue home care for wound care, increased his oxygen supplies at home and he was discharged home at his request."
The pt received immunizations on 04/23/2002. Mom reports his right upper arm started to get sore and swell that night. Right deltoid area became red, and warm to touch.
This spontaneous report as received from a nurse refers to a 64 year old male patient. The patient's medical history and concurrent conditions were not provided. On 05-APR-2013 the patient was vaccinated with an expired dose of ZOSTAVAX lot # 0467AE, 0.65 ml, subcutaneous. Expiration date was 04-APR-2013. No concomitant medications were reported. No adverse effects were reported. No further information was available. Additional information has been requested.
Information has been received from a physician via a company medical science liaison referring to a male patient of unknown age. Information about concurrent condition, concomitant medication and medical history was not reported. The physician reported that on unspecified dates, the patient received two doses of GARDASIL (lots #, expiration dates, dose and route were not reported) for prophylaxis, respectively. On a separate unspecified date after receiving the two doses of GARDASIL, the patient developed anal dysplasia. It was unknown whether treatment was given to the patient for the adverse event. The outcome of the event was not reported. The reported did not provide the causality between the event and GARDASIL. Upon internal review, the event of anal dysplasia was considered to be medically significant.
Within 2-3 days of receiving the vaccine, I experienced numbness and tingling in my right arm. When it didn't go away after a day or two, I thought about what was different about that arm than the other arm. I tried to recall sleeping on it weird or carrying something out of the ordinary. And then I remembered the tetanus shot. That is the only thing I've ever come up with that was unusual. The numbness, but mostly the tingling sensation I am certain was a pinched nerve or whatever can make that feeling happen was quite intense for a while, in that I was aware of it here and there throughout the day. I got used to holding my arm in ways that wouldn't aggravate it, but I mostly got used to the sensation. After about six weeks, I would mostly experience it in the mornings or any time I rested/sagged my shoulders, and the feeling ebbed a bit most of the rest of the time--or I got used to it. I kept thinking it was getting better, and after about 3-4 months (it was quite gradual) it was okay again. I haven't suffered anything similar since that time. I should note that it was primarily my upper arm--occasionally the tingling may have gone a bit past my elbow, but mostly it was contained within my upper right arm.
Stomach virus; This spontaneous case was reported by a consumer and describes the occurrence of GASTROENTERITIS VIRAL (Stomach virus) in an elderly male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Crohn's disease.    There was no reported medical history.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced GASTROENTERITIS VIRAL (Stomach virus). At the time of the report, GASTROENTERITIS VIRAL (Stomach virus) outcome was unknown.     The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.  No concomitant medications were reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
heart raced 4 minutes after injection, felt like i could feel the vaccine really hit my bloodstream fully, could?ve been a panic attack. the hives showed up at 6:45, dime sized, and stayed for three weeks with varying intensity and location. mostly on my stomach, hips, and occasionally lower back
NOT ABLE TO SLEEP; LEFT ARM SORENESS; SHOULDER AND UNDER NECK MUSCLE SORENESS; CHILLS; This spontaneous report received from a patient concerned a 74 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821286, expiry: UNKNOWN) dose was not reported, administered on 11-MAY-2021 for prophylactic vaccination. Concomitant medications included acetylsalicylic acid. On 11-MAY-2021, the subject experienced chills. On 24-MAY-2021, the subject experienced shoulder and under neck muscle soreness. On 07-JUN-2021, the subject experienced not able to sleep. On 07-JUN-2021, the subject experienced left arm soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from not able to sleep, and left arm soreness on 14-JUN-2021, chills on 11-MAY-2021, and shoulder and under neck muscle soreness on 24-MAY-2021. This report was non-serious.
Pt recv vax on 4/8/99; on 4/18/99 pt exp sore throat, fever, achy joints, red rash on trunk & abdomen
Pt has a history of Parkinson's Dementia, DM, and a prior CVA. He was seen in the ED on 9/16 with abdominal pain and was found to be incidentally COVID positive. He was discharged home. After arriving home he lost his balance in the garage. He now has a right intertrochanteric fracture.
No additional adverse effect reported; VARIVAX that underwent a temperature excursion was administered; This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 12-JUL-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot number: T033166, expiration date: 29-SEP-2022; dose and route of administration not provided). The vaccine was stored in temperature 60 degrees Fahrenheit for 12 minutes. There was previous temperature excursion in temperatures from -10 to 8 degrees Celsius (-4.5 degrees Celsius) for 2 hours and 20 minutes. Digital data lodger was involved. No adverse event was reported.   This is one of the two reports from the same reporter.; Sender's Comments:  US-009507513-2107USA004607: